Type 1 Diabetes. Type 1 diabetes mellitus
Conditions
Interventions
Intervention 1: The intervention group receives probiotics. Patients take two capsules daily for three months, each containing a combined probiotic of Lactobacillus and Bifidobacterium (Biodiab capsul
Sponsors
Yazd University of Medical Sciences
Eligibility
Sex/Gender
All
Age
5 Years to 18 Years
Inclusion criteria
Inclusion criteria: Age 5 to 18 years. Diagnosis of type 1 diabetes by a pediatric endocrinologist. Diagnosis of type 1 diabetes at least 6 months before the start of the study. Receiving insulin therapy with an appropriate dose and appropriate duration. Absence of other secondary diseases . Not consuming probiotic products for at least two weeks before the start of the study. No complications of diabetes. Not consuming antibiotic for at least two weeks before the start of the study.
Exclusion criteria
Exclusion criteria: Unwillingness to participatie in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ?The level of fasting blood glucose. Timepoint: Before and after intervention (during intervention 3 months). Method of measurement: The evaluation of fasting blood glucose is done via Glucometer diaban and Pars Azmoon company kit. | — |
Secondary
| Measure | Time frame |
|---|---|
| Glycosylated Hemoglobin. Timepoint: Before and after intervention (duration of intervention 3 months). Method of measurement: HPLC instrument. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Sadat Sofari
Yazd University of Medical Sciences
Outcome results
None listed